Abstract | OBJECTIVE: Eosinophilic oesophagitis (EoE) is a chronic inflammatory condition of the oesophagus with limited treatment options. No previous transgenic model has specifically targeted the oesophageal mucosa to induce oesophageal eosinophilia. DESIGN: We developed a mouse model that closely resembles EoE by utilising oxazolone haptenation in mice with transgenic overexpression of an eosinophil poietic and survival factor (interleukin (IL)-5) in resident squamous oesophageal epithelia. RESULTS: Overexpression of IL-5 in the healthy oesophagus was achieved in transgenic mice (L2-IL5) using the squamous epithelial promoter Epstein-Barr virus ED-L2. Oxazolone-challenged L2-IL5 mice developed dose-dependent pan-oesophageal eosinophilia, including eosinophil microabscess formation and degranulation as well as basal cell hyperplasia. Moreover, oesophagi expressed increased IL-13 and the eosinophil agonist chemokine eotaxin-1. Treatment of these mice with corticosteroids significantly reduced eosinophilia and epithelial inflammation. CONCLUSIONS: L2-IL5 mice provide a novel experimental model that can potentially be used in preclinical testing of EoE-related therapeutics and mechanistic studies identifying pathogenetic features associated with mucosal eosinophilia.
|
Authors | Joanne C Masterson, Eóin N McNamee, Lindsay Hosford, Kelley E Capocelli, Joseph Ruybal, Sophie A Fillon, Alfred D Doyle, Holger K Eltzschig, Anil K Rustgi, Cheryl A Protheroe, Nancy A Lee, James J Lee, Glenn T Furuta |
Journal | Gut
(Gut)
Vol. 63
Issue 1
Pg. 43-53
(Jan 2014)
ISSN: 1468-3288 [Electronic] England |
PMID | 23161496
(Publication Type: Evaluation Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents
- Biomarkers
- Interleukin-5
- Viral Regulatory and Accessory Proteins
- Oxazolone
- Dexamethasone
|
Topics |
- Animals
- Anti-Inflammatory Agents
(therapeutic use)
- Biomarkers
(metabolism)
- Dexamethasone
(therapeutic use)
- Disease Models, Animal
- Eosinophilic Esophagitis
(drug therapy, etiology, metabolism)
- Epithelium
- Herpesvirus 4, Human
- Interleukin-5
(genetics, metabolism)
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
(genetics, immunology, metabolism)
- Oxazolone
- Real-Time Polymerase Chain Reaction
- Reverse Transcriptase Polymerase Chain Reaction
- Up-Regulation
- Viral Regulatory and Accessory Proteins
|